UBS/CALL/ABBOTT LABORATORIES/100/0.1/20.12.24 Share Price

Warrant

CH1252580431

Delayed Deutsche Boerse AG 13:00:33 27/06/2024 BST
0.91 EUR -5.21% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/100/0.1/20.12.24
Current month+26.32%
1 month+1.05%
Date Price Change
27/06/24 0.91 -5.21%
26/06/24 0.96 -1.03%
25/06/24 0.97 -3.00%
24/06/24 1 -0.99%
21/06/24 1.01 -5.61%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:00 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UL2S37
ISINCH1252580431
Date issued 23/02/2023
Strike 100 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 1.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.44
Lowest since issue 0.71
Spread 0.1
Spread %9.90%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus